Third Quarter 2013 Regulatory Capital Disclosures
The Goldman Sachs Group, Inc.
Regulatory
Capital
Disclosures
For the quarterly period ended
THE GOLDMAN SACHS GROUP, INC.
Regulatory Capital Disclosures
Introduction
The Goldman Sachs Group, Inc. (
The purpose of these disclosures is to provide information on our risk management practices and regulatory capital ratios, as required under the revised market risk regulatory capital requirements. These disclosures should be read in conjunction with our most recent Quarterly Report on Form 10-Q and our most recent Annual Report on Form 10-K. References to "Quarterly Report on Form 10-Q" are to our Quarterly Report on Form 10-Q for the quarterly period ended
Measures of exposures and other metrics disclosed in this report may not be based on
|
|
| 1 |
THE GOLDMAN SACHS GROUP, INC.
Regulatory Capital Disclosures
Overview of Regulatory Capital Ratios
As required under the
In evaluating our regulatory capital ratios, the following matters should be considered.
Fair Value. The inventory reflected on our condensed consolidated statements of financial condition as "financial instruments owned, at fair value" and "financial instruments sold, but not yet purchased, at fair value" and certain other financial assets and financial liabilities, are accounted for at fair value (i.e., marked-to-market), with related gains or losses generally recognized in our condensed consolidated statements of earnings and, therefore, in Tier 1 common capital and Tier 1 capital. The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The use of fair value to measure financial instruments is fundamental to our risk management practices and is our most critical accounting policy. The daily discipline of marking substantially all of our inventory to current market levels is an effective tool for assessing and managing risk and provides transparent and realistic insight into our financial exposures. The use of fair value is an important aspect to consider when evaluating our capital base and our capital ratios; it is also a factor used to determine the classification of positions into the banking book and trading book, as discussed further below.
For additional information regarding the determination of fair value under
__________
Financial Condition and Results of Operations - Critical Accounting Policies - Fair Value" in Part I, Item 2 of our Quarterly Report on Form 10-Q.
Banking Book / Trading Book Classification. In order to determine the appropriate regulatory capital treatment for our exposures, positions must be first classified into either "banking book" or "trading book." Positions are classified as banking book unless they qualify to be classified as trading book.
Banking book positions may be accounted for at amortized cost, fair value or under the equity method; they are not generally held "for the purpose of short-term resale or with the intent of benefiting from actual or expected short-term price movements or to lock in arbitrage profits2." Banking book positions are subject to credit risk capital requirements. Credit risk represents the potential for loss due to the default or deterioration in credit quality of a counterparty (e.g., an OTC derivatives counterparty or a borrower) or an issuer of securities or other instruments we hold. See "Risk-Weighted Assets - Credit RWAs" for additional details.
Trading book positions generally meet the following criteria: they are assets or liabilities that are accounted for at fair value; they are risk managed using a Value-at-Risk (VaR) internal model; and they are positions that we hold as part of our market-making businesses "for the purpose of short-term resale or with the intent of benefiting from actual or expected short-term price movements or to lock in arbitrage profits2." In accordance with the
- See "Requirements for internal models" in Section 3. Requirements for Application of the Market Risk Capital Rule of Appendix E to 12 CFR Part-225
- Capital Adequacy Guidelines for Bank Holding Companies: Market Risk. - See definition of "Trading position" in Section 2. Definitions of Appendix E to 12 CFR Part 225 - Capital Adequacy Guidelines for Bank Holding Companies: Market Risk.
THE GOLDMAN SACHS GROUP, INC.
Regulatory Capital Disclosures
Consolidated Regulatory Capital Ratios
The table below presents information about our regulatory capital ratios and Tier 1 leverage ratio, as implemented by the
Table 1: Regulatory Capital Ratios
|
$ in millions |
As of |
|||
|
Tier 1 |
|
$ |
61,827 |
|
|
Tier 1 |
Capital |
$ |
71,051 |
|
|
Tier 2 |
Capital |
$ |
13,541 |
|
|
Total Capital |
$ |
84,592 |
||
|
Risk-Weighted Assets |
$ |
436,730 |
||
|
Tier 1 Common Ratio |
14.2 % |
|||
|
Tier 1 Capital Ratio |
16.3 % |
|||
|
Total Capital Ratio |
19.4 % |
|||
|
Average Adjusted Assets |
$ |
896,712 |
||
|
Tier 1 Leverage Ratio |
7.9 % |
The revised market risk regulatory capital requirements became effective on
The Tier 1 capital ratio is defined as Tier 1 capital divided by RWAs, and the Total capital ratio is defined as Total capital divided by RWAs.
The Tier 1 common ratio is defined as Tier 1 common capital divided by RWAs. We believe that the Tier 1 common ratio is meaningful because it is one of the measures that we, our regulators and investors use to assess capital adequacy.
The Tier 1 leverage ratio is defined as Tier 1 capital divided by average adjusted total assets (which includes adjustments for goodwill and identifiable intangible assets, and the carrying value of equity investments in non-financial companies that are subject to deductions from Tier 1 capital). The minimum Tier 1 leverage ratio is currently 3% for bank holding companies that have received the highest supervisory rating under
The
The revised market risk regulatory capital requirements referenced above are also a part of these rules and will ultimately be reflected in our 2013 Capital Framework ratios when they become effective. For additional information on the 2013 Capital Framework and other announced and proposed changes that will impact our regulatory capital ratios, regulatory leverage ratios and assessments of capital adequacy in the future, see "Regulatory Reform."
THE GOLDMAN SACHS GROUP, INC.
Regulatory Capital Disclosures
For regulatory purposes, our Total capital base is divided into three main categories, namely Tier 1 common capital, Tier 1 capital and Tier 2 capital as follows:
- Tier 1 common capital is comprised of common shareholders' equity, after giving effect to deductions for disallowed items (for example, goodwill and intangible assets) and other adjustments;
- Tier 1 capital is comprised of Tier 1 common capital plus other qualifying capital instruments such as perpetual non- cumulative preferred stock and junior subordinated debt issued to trusts (a portion of the latter is being phased-out of Tier 1 capital, as required by the Dodd-Frank Act) and other adjustments; and
- Total capital is comprised of Tier 1 capital plus Tier 2 capital. Tier 2 capital includes qualifying subordinated debt, redesignated junior subordinated debt issued to trusts, allowance for loan and lease losses (limited to 1.25% of RWAs) and other adjustments.
Capital elements are subject to various regulatory limits and restrictions. In general, to qualify as an element of Tier 1 or Tier 2 capital, an instrument must be fully paid and effectively unsecured. Accordingly, if a bank holding company has purchased its own capital instrument, or has directly or indirectly funded the purchase thereof, that instrument generally is disqualified from inclusion in regulatory capital. A qualifying Tier 1 or Tier 2 capital instrument must also be subordinated to all senior indebtedness of the organization. Additionally, Tier 1 capital must represent at least 50% of qualifying Total capital.
Assets that are deducted from capital in computing the numerator of the capital ratios are excluded from the computation of RWAs in the denominator of the ratios.
The table below presents information on the components of our regulatory capital structure, which are based on Basel I, as implemented by the
- Equity investments in certain entities primarily represent a portion of our nonconsolidated equity investments.
- Disallowed deferred tax assets represent certain deferred tax assets that are excluded from regulatory capital based upon an assessment which, in addition to other factors, includes an estimate of future taxable income.
- Debt valuation adjustment represents the cumulative change in the fair value of our unsecured borrowings attributable to the impact of changes in our own credit spreads (net of tax at the applicable tax rate).
- Other adjustments within our Tier 1 common capital primarily includes the cumulative change in our pension and postretirement liabilities (net of tax at the applicable tax rate) and investments in certain nonconsolidated entities.
- Qualifying subordinated debt represents subordinated debt issued by
Group Inc. with an original term to maturity of five years or greater. The outstanding amount of subordinated debt qualifying for Tier 2 capital is reduced, or discounted, upon reaching a remaining maturity of five years.
Table 2: Capital Structure
|
in millions |
As of |
|
|
Common stock |
$ |
8 |
|
Restricted stock units and employee stock options |
3,701 |
|
|
Additional paid-in capital |
48,930 |
|
|
Retained earnings |
69,975 |
|
|
Accumulated other comprehensive loss |
(600) |
|
|
Stock held in treasury, at cost |
(51,598) |
|
|
Common Shareholders' Equity |
$ |
70,416 |
|
Less: |
(3,702) |
|
|
Less: Identifiable intangible assets |
(756) |
|
|
Less: Equity investments in certain entities |
(3,474) |
|
|
Less: Disallowed deferred tax assets |
(753) |
|
|
Less: Debt valuation adjustment |
(114) |
|
|
Other adjustments |
210 |
|
|
Tier 1 |
$ |
61,827 |
|
Perpetual non-cumulative preferred stock |
7,200 |
|
|
Junior subordinated debt issued to trusts1 |
2,063 |
|
|
Other adjustments |
(39) |
|
|
Tier 1 Capital |
$ |
71,051 |
|
Qualifying subordinated debt |
12,730 |
|
|
Junior subordinated debt issued to trusts1 |
687 |
|
|
Other adjustments |
124 |
|
|
Tier 2 Capital |
$ |
13,541 |
|
Total Capital |
$ |
84,592 |
1. On
THE GOLDMAN SACHS GROUP, INC.
Regulatory Capital Disclosures
The table below presents the changes in Tier 1 common capital,
Tier 1 capital and Tier 2 capital for the three months ended
|
Table 3: |
Capital Rollforward |
||
|
in millions |
Three Months Ended |
||
|
Tier 1 |
|||
|
Balance, beginning of period |
$ |
61,903 |
|
|
Decrease in restricted stock units and employee |
(121) |
||
|
stock options |
|||
|
Increase in additional paid-in capital |
168 |
||
|
Net earnings |
1,517 |
||
|
Dividends and dividend-equivalents declared |
(325) |
||
|
Increase in accumulated other comprehensive loss |
(17) |
||
|
Common stock repurchases |
(1,650) |
||
|
Common stock reissued and other |
1 |
||
|
Change in common shareholders' equity |
(427) |
||
|
Increase in goodwill |
(3) |
||
|
Decrease in identifiable intangible assets |
39 |
||
|
Decrease in equity investments in certain entities |
313 |
||
|
Increase in disallowed deferred tax assets |
(38) |
||
|
Change in debt valuation adjustment |
42 |
||
|
Change in other adjustments |
(2) |
||
|
Change in deductions for disallowed items |
351 |
||
|
Balance, end of period |
$ |
61,827 |
|
|
Tier 1 Capital |
|||
|
Balance, beginning of period |
$ |
71,141 |
|
|
Net decrease in Tier 1 common capital |
(76) |
||
|
Change in other adjustments |
(14) |
||
|
Balance, end of period |
$ |
71,051 |
|
|
Tier 2 Capital |
|||
|
Balance, beginning of period |
$ |
13,339 |
|
|
Increase in qualifying subordinated debt |
157 |
||
|
Change in other adjustments |
45 |
||
|
Balance, end of period |
$ |
13,541 |
|
|
Total Capital |
$ |
84,592 |
THE GOLDMAN SACHS GROUP, INC.
Regulatory Capital Disclosures
Risk-Weighted Assets
Overview
RWAs under the
Table 4: Risk-Weighted Assets
|
in millions |
As of |
|
|
Credit RWAs |
||
|
OTC derivatives |
$ |
91,835 |
|
Commitments and guarantees1 |
43,812 |
|
|
Securities financing transactions2 |
44,958 |
|
|
Other3 |
88,383 |
|
|
Total Credit RWAs |
$ |
268,988 |
|
Market RWAs |
||
|
Regulatory VaR |
$ |
14,325 |
|
Stressed VaR |
35,850 |
|
|
Incremental risk |
9,825 |
|
|
Comprehensive risk |
23,163 |
|
|
Specific risk |
84,579 |
|
|
Total Market RWAs |
$ |
167,742 |
|
Total RWAs4 |
$ |
436,730 |
- Principally includes certain commitments to extend credit and letters of credit.
- Represents resale and repurchase agreements and securities borrowed and loaned transactions.
- Principally includes receivables from customers, certain loans, other assets, and cash and cash equivalents.
- Under the current regulatory capital framework, there is no explicit requirement for Operational risk.
The table below presents the changes in RWAs for the three months ended
Table 5: Risk-Weighted Assets Rollforward
|
in millions |
Three Months Ended |
||
|
RWAs Balance, beginning of period |
$ |
457,461 |
|
|
Credit RWAs |
|||
|
Decrease in OTC derivatives |
(1,820) |
||
|
Increase in commitments and guarantees |
725 |
||
|
Decrease in securities financing transactions |
(3,181) |
||
|
Change in other |
(281) |
||
|
Change in Credit RWAs |
$ |
(4,557) |
|
|
Market RWAs |
|||
|
Change in regulatory VaR |
- |
||
|
Decrease in stressed VaR |
(3,300) |
||
|
Decrease in incremental risk |
(9,588) |
||
|
Increase in comprehensive risk |
2,350 |
||
|
Decrease in specific risk |
(5,636) |
||
|
Change in Market RWAs |
$ |
(16,174) |
|
|
Total RWAs Balance, end of period |
$ |
436,730 |
Credit RWAs decreased
.
THE GOLDMAN SACHS GROUP, INC.
Regulatory Capital Disclosures
Credit RWAs
RWAs for credit risk reflect amounts for on-balance sheet and off-balance sheet exposures. Credit risk requirements for on- balance sheet assets, such as receivables and cash, are generally based on the balance sheet value. Credit risk requirements for securities financing transactions are determined based upon the positive net exposure for each trade, and include the effect of counterparty netting and collateral, as applicable. For off-balance sheet exposures, including commitments and guarantees, a credit equivalent amount is calculated based on the notional amount of each trade. Requirements for OTC derivatives are based on a combination of positive net exposure and a percentage of the notional amount of each trade, and include the effect of counterparty netting and collateral, as applicable. All such assets and exposures are then assigned a risk weight depending on, among other things, whether the counterparty is a sovereign, bank or a qualifying securities firm or other entity (or if collateral is held, depending on the nature of the collateral).
Market RWAs
As previously noted, our covered positions are subject to market risk capital requirements which are based on either predetermined levels set by regulators or on internal models, which are subject to various qualitative and quantitative parameters. The revised market risk regulatory capital rules require that a bank holding company must obtain the prior written approval of its regulators before using any internal model to calculate its risk-based capital requirement1.
RWAs for market risk are computed using the following internal models: Value-at-Risk (VaR), Stressed VaR (SVaR), Incremental risk and Comprehensive risk (which also includes a surcharge). In addition, the Specific risk measure is also used to compute RWAs for market risk, under the standardized measurement method, for certain securitized and non-securitized covered positions by applying risk-weighting factors predetermined by regulators, to positions after applicable netting is performed. As defined in the
Regulatory VaR. VaR is the potential loss in value of inventory positions due to adverse market movements over a defined time horizon with a specified confidence level. We use a single VaR model for risk management (positions subject to VaR limits) and for regulatory capital purposes (covered positions). However, regulatory VaR will differ from risk management VaR, due to different time horizons and confidence levels (10-day and 99% for regulatory VaR vs. one-day and 95% for risk management VaR), as well as differences in the scope of positions on which VaR is calculated.
The VaR model captures risks including interest rates, equity prices, currency rates and commodity prices. As such, VaR facilitates comparison across portfolios of different risk characteristics. VaR also captures the diversification of aggregated risk at the firmwide level. Categories of market risk include the following:
- Interest rate risk: results from exposures to changes in the level, slope and curvature of yield curves, the volatilities of interest rates, mortgage prepayment speeds and credit spreads.
- Equity price risk: results from exposures to changes in prices and volatilities of individual equities, baskets of equities and equity indices.
- Currency rate risk: results from exposures to changes in spot prices, forward prices and volatilities of currency rates.
- Commodity price risk: results from exposures to changes in spot prices, forward prices and volatilities of commodities, such as electricity, natural gas, crude oil, petroleum products, and precious and base metals.
In accordance with the revised market risk regulatory capital requirements, we evaluate the accuracy of our VaR model through daily backtesting. The results of the backtesting determine the size of the VaR multiplier used to compute RWAs. See "Regulatory VaR Backtesting Results" for additional information.
__________
1. See "Requirements for internal models" in Section 3. Requirements for Application of the Market Risk Capital Rule of Appendix E to 12 CFR Part-225
- Capital Adequacy Guidelines for Bank Holding Companies: Market Risk.
THE GOLDMAN SACHS GROUP, INC.
Regulatory Capital Disclosures
The table below presents by risk category our period-end, high, low and mean of the average daily Regulatory VaR. Average, per the revised market risk regulatory capital requirements, is determined based on the average daily Regulatory VaR over the preceding 60 business days.
Table 6: Regulatory VaR
|
As of |
||||||
|
|
||||||
|
in millions |
|
|||||
|
Regulatory VaR |
$ |
382 |
||||
|
VaR x Multiplier |
1,146 1 |
|||||
|
RWAs |
$ |
14,325 |
||||
|
Three Months Ended |
||||||
|
As of |
|
|||||
|
|
High |
Low |
Mean |
|||
|
|
$ |
382 |
|
|
|
|
|
Interest rates |
360 |
360 |
346 |
351 |
||
|
Equity prices |
126 |
128 |
116 |
122 |
||
|
Currency rates |
119 |
173 |
119 |
146 |
||
|
Commodity prices |
93 |
99 |
93 |
96 |
||
|
Diversification 2 |
(316) |
(330) |
- Regulatory VaR is subject to a regulatory multiplier that is set at a minimum of three (which is the multiplier used in this table) and can be increased up to four, depending upon the number of backtesting exceptions. See "Regulatory VaR Backtesting Results." This result is further multiplied by 12.5 to convert into RWAs.
- Diversification effect in the table above represents the difference between total VaR and the sum of the VaRs for the four risk categories. This effect arises because the four market risk categories are not perfectly correlated.
Stressed VaR. SVaR is the potential loss in value of inventory positions during a period of significant market stress. SVaR is calculated at a 99% confidence level over a 10-day horizon using market data inputs from a continuous 12-month period of stress. We identify the stressed period by comparing VaR using market data inputs from different historical periods.
The table below presents our period-end, high, low and mean of the average weekly SVaR. Average, per the revised market risk regulatory capital requirements, is determined based on the average weekly amount for the preceding 12 weeks.
Table 7: Stressed VaR
|
As of |
Three Months Ended |
|||||
|
|
|
|||||
|
in millions |
|
High |
Low |
Mean |
||
|
SVaR |
$ |
956 |
$ |
1,030 |
|
|
|
SVaR x Multiplier |
2,868 |
1 |
||||
|
RWAs |
$ |
35,850 |
1. SVaR is subject to the same regulatory multiplier used for Regulatory VaR and is further multiplied by 12.5 to convert into RWAs.
Incremental Risk. Incremental risk is the potential loss in value of non-securitized inventory positions due to the default or credit migration of issuers of financial instruments over a one-year time horizon. As required by the revised market risk regulatory capital rules this measure is calculated at a 99.9% confidence level over a one-year time horizon. It uses a multi- factor model assuming a constant level of risk. When assessing the risk, we take into account market and issuer- specific concentration, credit quality, liquidity horizons and correlation of default and migration risk. The liquidity horizon is calculated based upon the size of exposures and the speed at which we can reduce risk, by hedging or unwinding positions, given our experience during a historical stress period, and is subject to the prescribed regulatory minimum.
The table below presents our period-end, high, low and mean of the maximum of the average weekly Incremental risk measure or the point-in-time measure. Average, per the revised market risk regulatory capital requirements, is determined based on the average weekly amount over the preceding 12 weeks.
Table 8: Incremental Risk
|
As of |
Three Months Ended |
||||||
|
|
|
||||||
|
in millions |
|
1 |
High |
Low |
Mean |
||
|
Incremental Risk |
$ |
786 |
$ |
1,463 |
|
1,055 |
|
|
RWAs |
$ |
9,825 |
1. In order to convert the results of Incremental risk into RWAs, it is multiplied by 12.5.
THE GOLDMAN SACHS GROUP, INC.
Regulatory Capital Disclosures
Comprehensive Risk. Comprehensive risk is the potential loss in value, due to price risk and defaults, within the firm's credit correlation positions. A credit correlation position is defined as a securitization position for which all or substantially all of the value of the underlying exposures is based on the credit quality of a single company for which a two-way market exists, or indices based on such exposures for which a two-way market exists, or hedges of these positions (which are typically not securitization positions).
As required by the revised market risk regulatory capital requirements, Comprehensive risk comprises a model-based measure and a surcharge based on the standardized measurement method. The modeled measure is calculated at a 99.9% confidence level over a one-year time horizon applying a constant level of risk. The model comprehensively covers price risks including nonlinear price effects and takes into account contractual structure of cash flows, the effect of multiple defaults, credit spread risk, volatility of implied correlation, recovery rate volatility and basis risk. The liquidity horizon is based upon our experience during a historical stress period, subject to the prescribed regulatory minimum.
The surcharge is 8% of the standardized specific risk add-on. For detail on the calculation of the add-on for securitization positions, see "Specific Risk - Securitization Positions" below, and for detail on the calculation of the add-on for hedges see "Specific Risk - Other Specific Risk" below.
As of
The following table presents our period-end, high, low and mean of the maximum of the average weekly Comprehensive risk measure or the point-in-time measure, inclusive of both modeled and non-modeled components. Average, per the revised market risk regulatory capital requirements, is determined based on the average weekly amount for the preceding 12 weeks.
Table 9: Comprehensive Risk
|
As of |
Three Months Ended |
|||||
|
|
|
|||||
|
in millions |
|
High |
Low |
Mean |
||
|
Comprehensive Risk |
$ |
1,853 |
1,2 |
|
|
|
|
RWAs |
$ |
23,163 |
- In order to convert the Comprehensive risk measure into RWAs, it is multiplied by 12.5.
- These results include a surcharge of
$1.05 billion on credit correlation positions.
Model Review and Validation
The models discussed above, which are used to determine Regulatory VaR, SVaR, Incremental risk and Comprehensive risk, are subject to review and validation at least annually by our independent model validation group, which consists of quantitative professionals who are separate from model developers. This review includes:
- a critical evaluation of the model, its theoretical soundness and adequacy for intended use;
- verification of the testing strategy utilized by the model developers to ensure that the model functions as intended; and
- verification of the suitability of the calculation techniques incorporated in the model.
Our models are regularly reviewed and enhanced in order to incorporate changes in the composition of covered positions, as well as variations in market conditions. Prior to implementing significant changes to our assumptions and/or models, we perform model validation and test runs. Additionally, we evaluate the accuracy of our Regulatory VaR model through daily backtesting. See "Regulatory VaR Backtesting Results" for further detail.
Attachments
Disclaimer
The Goldman Sachs Group Inc. published this content on



Goldman Sachs Bank USA and Subsidiaries – 2021 Annual Report
2017 Annual Dodd-Frank Act Stress Test Disclosure
Advisor News
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
- More investors will seek comprehensive financial planning
- Midlife planning for women: why it matters and how advisors should adapt
More Advisor NewsAnnuity News
- LIMRA: Annuity sales notch 10th consecutive $100B+ quarter
- AIG to sell remaining shares in Corebridge Financial
- Corebridge Financial, Equitable Holdings post Q1 earnings as merger looms
- AM Best Assigns Credit Ratings to Calix Re Limited
- Transamerica introduces new RILA with optional income features
More Annuity NewsHealth/Employee Benefits News
- All about AHCCCS: Navigating Arizona Medicaid’s changing landscape
- GOVERNOR SIGNS BIOMARKER TESTING COVERAGE BILL
- REGULATION OF AI IN PRIOR AUTHORIZATION AND CLAIMS REVIEW: A LOOK AT FEDERAL AND STATE CONSUMER PROTECTIONS
- LEADING HEALTH ORGANIZATIONS URGE NC LAWMAKERS TO RECONSIDER PROPOSAL IMPLEMENTING MEDICAID CUTS
- Tracing the decline of health care in America
More Health/Employee Benefits NewsLife Insurance News
- AM Best Assigns Credit Ratings to Tokio Marine Newa Insurance Co., Ltd.
- Earnings roundup: Prudential works to save ‘unique’ Japanese market
- How life insurance became a living-benefits strategy
- Financial Focus : Keep your beneficiary choices up to date
- Equitable-Corebridge merger casts shadow over life insurance earnings
More Life Insurance News